Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review (Q38819920)

6 September 2017

0 references

Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review (English)

1 reference

6 September 2017

1 reference

Sheena G Sullivan

4

0 references

Benjamin J. Cowling

series ordinal

2

object named as

Benjamin J Cowling

1 reference

6 September 2017

Vivian K Leung

1

0 references

author name string

Shuo Feng

series ordinal

3

1 reference

6 September 2017

publication date

1 April 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

21

1 reference

6 September 2017

issue

16

1 reference

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

The case test-negative design for studies of the effectiveness of influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

The test-negative design for estimating influenza vaccine effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

A solution to the problem of separation in logistic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 20

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2016.21.16.30202

10.2807/1560-7917.ES.2016.21.16.30202

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference